181 related articles for article (PubMed ID: 26828139)
1. 18F-FDG PET/CT Diagnosis of Bronchopulmonary Carcinoids Versus Pulmonary Hamartomas.
Uhlén N; Grundberg O; Jacobsson H; Sundin A; Dobra K; Sánchez-Crespo A; Axelsson R; Kölbeck KG
Clin Nucl Med; 2016 Apr; 41(4):263-7. PubMed ID: 26828139
[TBL] [Abstract][Full Text] [Related]
2. Differential diagnostic value of
Zhao J; Wang H
Acad Radiol; 2022 Feb; 29 Suppl 2():S41-S46. PubMed ID: 33183953
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the role of [18F]FDG-PET/CT and [68Ga]DOTATOC-PET/CT in differentiating typical and atypical pulmonary carcinoids.
Jindal T; Kumar A; Venkitaraman B; Meena M; Kumar R; Malhotra A; Dutta R
Cancer Imaging; 2011 Jun; 11(1):70-5. PubMed ID: 21697027
[TBL] [Abstract][Full Text] [Related]
4. Multicenter comparison of 18F-FDG and 68Ga-DOTA-peptide PET/CT for pulmonary carcinoid.
Lococo F; Perotti G; Cardillo G; De Waure C; Filice A; Graziano P; Rossi G; Sgarbi G; Stefanelli A; Giordano A; Granone P; Rindi G; Versari A; Rufini V
Clin Nucl Med; 2015 Mar; 40(3):e183-9. PubMed ID: 25608152
[TBL] [Abstract][Full Text] [Related]
5. Integrated FDG-PET/CT imaging is useful in the approach to carcinoid tumors of the lung.
Stefani A; Franceschetto A; Nesci J; Aramini B; Proli C; Kaleci S; Casolo A; Massi L; Casali C; Morandi U
J Cardiothorac Surg; 2013 Dec; 8():223. PubMed ID: 24305515
[TBL] [Abstract][Full Text] [Related]
6. Re: 18F-FDG PET/CT Diagnosis of Bronchopulmonary Carcinoids Versus Pulmonary Hamartomas.
Lococo F; Rufini V; Treglia G
Clin Nucl Med; 2017 Jan; 42(1):81. PubMed ID: 27607179
[No Abstract] [Full Text] [Related]
7. 18F-FDG PET/CT Diagnosis of Bronchopulmonary Carcinoids Versus Pulmonary Hamartomas: Reply.
Sundin A; Uhlén N; Axelsson R
Clin Nucl Med; 2017 Jan; 42(1):81-82. PubMed ID: 27607160
[No Abstract] [Full Text] [Related]
8. Are the 18F-FDG positron emission tomography/computed tomography findings in bronchopulmonary carcinoid tumors different than expected?
Alpay L; Lacin T; Kanbur S; Kiral H; Ersoz E; Bayram S; Dogruyol T; Baysungur V; Yalcinkaya I
Hell J Nucl Med; 2013; 16(3):213-7. PubMed ID: 24251310
[TBL] [Abstract][Full Text] [Related]
9. Contribution of
Tatcı E; Özmen Ö; Öztürk A; Demirağ F
Mol Imaging Radionucl Ther; 2021 Jun; 30(2):101-106. PubMed ID: 34082511
[TBL] [Abstract][Full Text] [Related]
10. Role of 68Ga-DOTATOC PET/CT in initial evaluation of patients with suspected bronchopulmonary carcinoid.
Venkitaraman B; Karunanithi S; Kumar A; Khilnani GC; Kumar R
Eur J Nucl Med Mol Imaging; 2014 May; 41(5):856-64. PubMed ID: 24435773
[TBL] [Abstract][Full Text] [Related]
11. A comparison of 68Ga-DOTATATE and 18F-FDG PET/CT in pulmonary neuroendocrine tumors.
Kayani I; Conry BG; Groves AM; Win T; Dickson J; Caplin M; Bomanji JB
J Nucl Med; 2009 Dec; 50(12):1927-32. PubMed ID: 19910422
[TBL] [Abstract][Full Text] [Related]
12. Use of integrated FDG PET/CT imaging in pulmonary carcinoid tumours.
Krüger S; Buck AK; Blumstein NM; Pauls S; Schelzig H; Kropf C; Schumann C; Mottaghy FM; Hombach V; Reske SN
J Intern Med; 2006 Dec; 260(6):545-50. PubMed ID: 17116005
[TBL] [Abstract][Full Text] [Related]
13. Growth of a solitary pulmonary nodule after 6years diagnosed as oncocytic carcinoid tumour with a high 18-fluorodeoxyglucose (18F-FDG) uptake in positron emission tomography-computed tomography (PET-CT).
Turan O; Ozdogan O; Gurel D; Onen A; Kargi A; Sevinc C
Clin Respir J; 2013 Jan; 7(1):e1-5. PubMed ID: 22129499
[TBL] [Abstract][Full Text] [Related]
14. The utility of fluorodeoxyglucose positron emission tomography in the evaluation of carcinoid tumors presenting as pulmonary nodules.
Daniels CE; Lowe VJ; Aubry MC; Allen MS; Jett JR
Chest; 2007 Jan; 131(1):255-60. PubMed ID: 17218584
[TBL] [Abstract][Full Text] [Related]
15. [Pulmonary carcinoid tumors].
Prosch H
Radiologe; 2017 May; 57(5):397-406. PubMed ID: 28405692
[TBL] [Abstract][Full Text] [Related]
16. The diagnostic and prognostic role of combined [
Albano D; Dondi F; Bauckneht M; Albertelli M; Durmo R; Filice A; Versari A; Morbelli S; Berruti A; Bertagna F
Eur Radiol; 2023 Jun; 33(6):4167-4177. PubMed ID: 36482218
[TBL] [Abstract][Full Text] [Related]
17. Is it possible to discriminate pulmonary carcinoids from hamartomas based on CT features?
Coruh AG; Kul M; Kuru Öz D; Yenigün B; Cansız Ersöz C; Özalp Ateş F; Atasoy Ç
Clin Imaging; 2020 Jun; 62():49-56. PubMed ID: 32066033
[TBL] [Abstract][Full Text] [Related]
18. Role of (68)Ga-DOTATOC PET/CT in the evaluation of primary pulmonary carcinoids.
Jindal T; Kumar A; Venkitaraman B; Dutta R; Kumar R
Korean J Intern Med; 2010 Dec; 25(4):386-91. PubMed ID: 21179276
[TBL] [Abstract][Full Text] [Related]
19. Marked 18-Fuorine-Fluorodeoxyglucose (FDG) Avidity of an Intrapulmonary Typical Carcinoid Tumor Manifesting as a Bronchocele in an Asymptomatic Middle-Aged Woman.
Saadé-Yordán C; McBurney-Henriquez E; González-Santoni R; Gurrea-Rosas C; Montalvo-Fitzpatrick J; Maldonado-Vargas JA
Am J Case Rep; 2017 Dec; 18():1390-1395. PubMed ID: 29282351
[TBL] [Abstract][Full Text] [Related]
20. [Sensitivity of PET with 18F-fluorodesoxyglucose in the diagnosis of neuroendocrine tumors of the lungs].
Tlostanova MS; Petrun'kin AM
Vopr Onkol; 2013; 59(4):505-8. PubMed ID: 24032228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
